Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate
Advocate for facilitating verification for the online presence of an entity
Inspection systems and methods for detecting defects on extreme ultraviolet mask blanks
Dual-box location aware and dual-bitmap voltage domain aware on-chip variation techniques
MEMS autofocus actuator
Mixture, especially spinning solution
System and method for measuring an analyte in a sample
  Randomly Featured Patents
Hydraulic dual-circuit brake system
Auxiliary drive apparatus
Apparatus of inspecting defect in semiconductor and method of the same
Integrated head assembly for a nuclear reactor
Mobile mixing device
Executing programs based on user-specified constraints
Automatic teller machine enclosure
Limited shift signal processing system and method
Tablet type input device
Macrocyclic polyethers